Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for METHODEN ZUR AUSLÖSUNG EINER IMMUNANTWORT DURCH VERABREICHUNG VON RNA
Details for 2011736499
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2011736499
Title / Product Name
METHODEN ZUR AUSLÖSUNG EINER IMMUNANTWORT DURCH VERABREICHUNG VON RNA
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2011736499
EP Publication Number
2590670
E-Number
920621
Language
EN
PCT Number
US11043104
Publication Date
15.05.2013 A
23.08.2017 B1
Registration Date
23.08.2017
AT Publication Date
15.09.2017
Application Date
06.07.2011
Registration Number
-
Priorities
06.07.2010
US
361789 P
IPC
A61K 39/00 20060101AFI20130204BHEP
Maximum Duration of Protection
06.07.2031
Owner
GlaxoSmithKline Biologicals SA
Rue de l'Institut 89
1330 Rixensart
BE
Representative
No representatives present
Inventor
GEALL, Andrew
c/o Novartis Vaccines And Diagnostics Inc. PO Box 8097
Emeryville, CA 94662-8097
US
RAMSAUER, Katrin
c/o Novartis Vaccines And Diagnostics Inc. PO Box 8097
Emeryville, CA 94662-8097
US
OTTEN, Gillis
c/o Novartis Vaccines And Diagnostics Inc. PO Box 8097
Emeryville, CA 94662-8097
US
MANDL, Christian
c/o Novartis Vaccines And Diagnostics Inc. PO Box 8097
Emeryville, CA 94662-8097
US